Abstract
significantly reduced in the losartan-based treatment group compared with atenolol, stroke incidence was still higher as compared with coronary heart disease [7]. The devastating consequences and the burden of stroke urge implementation of evidence-based preventive strategies. An interesting approach could be based on estimation of individual risk. The unique scale for specific assessment of stroke risk is based in the Framingham Heart Study population [8]. This scale, which uses a Cox proportional risk model, allows 10-year stroke risk to be calculated using several variables (age, systolic BP values, tobacco use, diabetes, LVH, atrial fibrillation, and established cardiovascular disease), and has been adapted for use in treated hypertensive patients and in patients with new-onset atrial fibrillation [9]. Although its value for
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
